Form D · Pharmaceuticals
Sprout Pharmaceuticals, Inc.
Raleigh, NC · CIK 0001545211
Offering snapshot reported Jun 8, 2015 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 22, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 8, 2015 | Initial | $50,000,008 | No comparison | 5 | SEC filing |
| Jul 11, 2014 | Initial | $4,303,856 | No comparison | 69 | SEC filing |
| Jul 26, 2013 | Amendment | $9,999,997 | $5,208,084vs Jun 25, 2013 | 88 | SEC filing |
| Jun 25, 2013 | Initial | $4,791,913 | No comparison | 63 | SEC filing |
| Jul 11, 2012 | Amendment | $20,000,000 | $2,445,659vs Jun 29, 2012 | 59 | SEC filing |
| Jun 29, 2012 | Initial | $17,554,341 | No comparison | 55 | SEC filing |
| Mar 21, 2012 | Initial | $5,000,000 | No comparison | 61 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-241312
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Jun 8, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert W. Dahl | Director |
| W. Robert Dahl | Director |
| Richard De Schutter | Director |
| Douglas Eckert | Director, Executive |
| Michael Ford | Director |
| Rich Franco | Executive |
| Braxton Goodrich | Director |
| Trygve Mikkelsen | Director |
| Matthew Petzold | Executive |
| James Pruden | Executive |
| Fred Pruden | Executive |
| James Symons | Executive |
| Anne Tomalin | Executive |
| Josephine Torrente | Executive |
| Cynthia Whitehead | Director, Executive |
| Robert S. Whitehead | Director, Executive |
| Anthony Wild | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4208 Six Forks Road Suite 1010
Raleigh, NC, 27609
Raleigh, NC, 27609